Haleos Labs Limited

BSE: 540679 NSE: SMSLIFE
Haleos Labs Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN L74930TG2006PLC050223 Incorporated 31 May 2006 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Listed - NSE: SMSLIFE · BSE: 540679 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹333.79 Cr
▼ 3.17% YoY
Computed EBITDA · FY 2026
₹47.11 Cr
▼ 5.59% YoY
Net profit · FY 2026
₹17.8 Cr
▼ 4.98% YoY
Authorised capital
₹3.5 Cr
Registered with MCA
Paid-up capital
₹3.02 Cr
Issued & subscribed
Open charges
₹133.44 Cr
Satisfied ₹67.83 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
558
Latest available

About Haleos Labs Limited

Data last updated: 14 July 2026

Haleos Labs Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 31 May 2006, the company has been in operation for over 20 years.

Registered with ROC Hyderabad under CIN L74930TG2006PLC050223. Listed on BSE: 540679 and NSE: SMSLIFE.

Capital: an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹3.02 Cr. Formerly known as Potluri Real Estate Private Limtied and Potluri Packaging Industries Private Limited. It is led by directors including Veeravenkata Satyanarayana Murthy Talluri and Sarath Kumar Pakalapati.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.19 – Iii Road No.71 Jubilee Hills Opp. Bharatiya Vidya Bhavan Public School, Hyderabad, Telangana, India – 500096.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹333.79 Cr, a decline of 3.17% compared to the previous year. The net worth stands at ₹229.56 Cr (up 8.26% YoY). Total assets are valued at ₹454.41 Cr (up 16.52% YoY).

The company has a workforce of approximately 558 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Sms Lifesciences. As per MCA filings, the company has open charges of ₹133.44 Cr and satisfied charges of ₹67.83 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smslife.in.

Company Details of Haleos Labs Limited
CIN L74930TG2006PLC050223
Registration Number 050223
Incorporation Date 31 May 2006
ROC Hyderabad
Listing Status Listed (BSE: 540679, NSE: SMSLIFE)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Veeravenkata Satyanarayana Murthy Talluri Managing Director Venkata Praveen Talluri Whole-Time Director Sudeepthi Gopineedi Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    smslife.in
  • Social Media
    Locked
  • Registered Address
    Plot No.19 – Iii Road No.71 Jubilee Hills Opp. Bharatiya Vidya Bhavan Public School, Hyderabad, Telangana, India – 500096
  • Industry
    Pharma, API Manufacturers
Company report
Haleos Labs Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Haleos Labs Limited report

Financials, compliance, directors, charges, ownership and filings for Haleos Labs Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Haleos Labs Limited

Haleos Labs Limited has undergone 4 name changes throughout its history. The current legal name is Haleos Labs Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Haleos Labs Limited Current
Potluri Real Estate Private Limtied Previous
Potluri Packaging Industries Private Limited Previous
Sms Lifesciences India Private Limited Previous

CIN History of Haleos Labs Limited

Haleos Labs Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74930TG2006PLC050223, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74930TG2006PLC050223 Current
U74930TG2006PTC050223 Previous
U45201AP2006PTC050223 Previous
U74930AP2006PTC050223 Previous

Associated Brands with Haleos Labs Limited

Haleos Labs Limited operates one associated brand: SMS LifeSciences. These brands represent Haleos Labs Limited's diversified market presence and brand portfolio.

Brand Description Website
SMS LifeSciences
Active Pharmaceutical Ingredients and intermediates are manufactured for pharmaceuticals. smslife.in

Competitors & Alternatives of Haleos Labs Limited

Brands and companies operating in the same space as Haleos Labs Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Haleos Labs Limited

Haleos Labs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Haleos Labs Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Haleos Labs Limited

Haleos Labs Limited is audited by Rambabu and Co (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Rambabu and Co (ICAI peer reviewed, certificate valid till 2027-06-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Haleos Labs Limited

Haleos Labs Limited is currently managed by 6 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Veeravenkata Satyanarayana Murthy Talluri
Also directs: Mahi Drugs Private Limited
Managing Director 01 Apr 2016 10 Years 4 Months Current
Sarath Kumar Pakalapati
Also directs: Mahi Drugs Private Limited, Shreyas Management And Services Private Limited
Director 25 May 2017 9 Years 3 Months Current
Venkata Praveen Talluri
Also directs: Mahi Drugs Private Limited
Whole-Time Director 21 Aug 2020 6 Years 0 Months Current
Sudeepthi Gopineedi Whole-Time Director 02 Sep 2021 4 Years 11 Months Current
Srinivas Samavedam
Also directs: Hics Academy Of Critical Care Llp, Crest Clinical Services Private Limited
Director 13 Nov 2021 4 Years 9 Months Current
Mannam Malakondaiah
Also directs: Beardsell Limited, Nsl Textiles Limited, Nsl Sez (Hyderabad) Private Limited and 1 more
Director 13 Nov 2021 4 Years 9 Months Current
View all directors

Financials of Haleos Labs Limited FY 2026 filings available

Haleos Labs Limited reported revenue of ₹333.79 Cr (down 3.17% YoY) for FY 2026.

Revenue · FY 2026
₹333.79 Cr ▼ 3.17%
Profit · FY 2026
₹17.8 Cr ▼ 4.98%
Computed EBITDA · FY 2026
₹47.11 Cr ▼ 5.59%
Revenue₹ Cr · Consolidated0200400FY 2020: ₹261 Cr261FY 2020FY 2021: ₹266 Cr · +1.8% YoY266+1.8%FY 2021FY 2022: ₹350 Cr · +31.7% YoY350+31.7%FY 2022FY 2023: ₹316 Cr · -9.8% YoY316-9.8%FY 2023FY 2024: ₹306 Cr · -3% YoY306-3%FY 2024FY 2025: ₹345 Cr · +12.7% YoY345+12.7%FY 2025FY 2026: ₹334 Cr · -3.2% YoY334-3.2%FY 2026
Net Profit₹ Cr · Consolidated0102030FY 2020: ₹10 Cr10.2FY 2020FY 2021: ₹14 Cr · +33.1% YoY13.6+33.1%FY 2021FY 2022: ₹25 Cr · +86.5% YoY25.3+86.5%FY 2022FY 2023: ₹11 Cr · -55% YoY11.4-55%FY 2023FY 2024: ₹6 Cr · -44.4% YoY6.3-44.4%FY 2024FY 2025: ₹19 Cr · +196% YoY18.7+196%FY 2025FY 2026: ₹18 Cr · -5% YoY17.8-5%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year050100Q1'25: ₹93 Cr · +24% YoY92.5+24%Q1'25Q2'25: ₹78 Cr · +13.3% YoY78.5+13.3%Q2'25Q3'25: ₹85 Cr · +17.4% YoY84.6+17.4%Q3'25Q4'25: ₹89 Cr · -1% YoY89.1-1%Q4'25Q1'26: ₹83 Cr · -10.9% YoY82.5-10.9%Q1'26Q2'26: ₹81 Cr · +3.7% YoY81.4+3.7%Q2'26Q3'26: ₹95 Cr · +12% YoY94.8+12%Q3'26Q4'26: ₹75 Cr · -15.7% YoY75.1-15.7%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹333.79 Cr ₹344.72 Cr ₹305.96 Cr ₹315.56 Cr ₹349.74 Cr ₹265.59 Cr ₹260.78 Cr
Other Income ₹2.43 Cr ₹4.86 Cr ₹3.83 Cr ₹3.07 Cr ₹2.07 Cr ₹1.78 Cr ₹2.28 Cr
Total Income ₹336.23 Cr ₹349.58 Cr ₹309.79 Cr ₹318.63 Cr ₹351.81 Cr ₹267.37 Cr ₹263.06 Cr
Cost of Materials Consumed ₹146.69 Cr ₹149.91 Cr ₹150.19 Cr ₹171.33 Cr ₹204.47 Cr ₹135.17 Cr ₹147.04 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹8.18 Cr ₹4.15 Cr ₹97.32 Lakh ₹7.52 Lakh -₹9.79 Cr ₹1.87 Cr ₹10.84 Cr
Employee Benefit Expense ₹65.38 Cr ₹59.54 Cr ₹49.27 Cr ₹43.43 Cr ₹39.9 Cr ₹30.66 Cr ₹26.56 Cr
Finance Costs ₹6.45 Cr ₹8.71 Cr ₹10.16 Cr ₹6.79 Cr ₹6.17 Cr ₹4.53 Cr ₹5.14 Cr
Depreciation & Amortisation ₹15.47 Cr ₹15 Cr ₹14.94 Cr ₹10.79 Cr ₹10.01 Cr ₹7.86 Cr ₹7.86 Cr
Other Expenses ₹85.23 Cr ₹86.09 Cr ₹74.41 Cr ₹71.98 Cr ₹81 Cr ₹67.72 Cr ₹50.95 Cr
Total Expenses ₹311.03 Cr ₹323.39 Cr ₹299.94 Cr ₹304.39 Cr ₹331.77 Cr ₹247.81 Cr ₹248.39 Cr
Profit Before Exceptional Items & Tax ₹25.2 Cr ₹26.19 Cr ₹9.85 Cr ₹14.24 Cr ₹20.04 Cr ₹19.57 Cr ₹14.67 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹2.35 Cr ₹12.69 Cr ₹0 ₹0
Profit Before Tax ₹25.2 Cr ₹26.19 Cr ₹9.85 Cr ₹16.59 Cr ₹32.73 Cr ₹19.57 Cr ₹14.67 Cr
Total Tax Expense ₹7.4 Cr ₹7.46 Cr ₹3.52 Cr ₹5.22 Cr ₹7.43 Cr ₹6.01 Cr ₹4.48 Cr
Net Profit ₹17.8 Cr ₹18.73 Cr ₹6.33 Cr ₹11.38 Cr ₹25.28 Cr ₹13.56 Cr ₹10.18 Cr
  attributable to Owners ₹17.31 Cr ₹20.11 Cr ₹9.09 Cr ₹11.46 Cr - - -
  attributable to NCI ₹48.83 Lakh -₹1.38 Cr -₹2.77 Cr -₹9.57 Lakh - - -
Other Comprehensive Income ₹11.14 Lakh ₹13.09 Lakh -₹45.44 Lakh ₹2.43 Lakh -₹3.59 Lakh -₹7.34 Lakh -₹31.27 Lakh
Total Comprehensive Income ₹17.91 Cr ₹18.86 Cr ₹5.87 Cr ₹11.4 Cr ₹25.24 Cr ₹13.48 Cr ₹9.87 Cr
EBITDA (computed) ₹47.11 Cr ₹49.9 Cr ₹34.94 Cr ₹31.82 Cr ₹36.22 Cr ₹31.96 Cr ₹27.67 Cr
Basic EPS ₹57.26 ₹66.51 ₹30.08 ₹37.92 ₹83.68 ₹44.84 ₹33.68
Diluted EPS ₹57.26 ₹66.51 ₹30.08 ₹37.92 ₹83.68 ₹44.84 ₹33.68
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹454.41 Cr ₹389.99 Cr ₹390.52 Cr ₹394.89 Cr
Non-current Assets ₹291.3 Cr ₹239.42 Cr ₹235.25 Cr ₹235.77 Cr
Current Assets ₹163.11 Cr ₹150.57 Cr ₹155.27 Cr ₹159.12 Cr
Property, Plant & Equipment ₹266.54 Cr ₹230.02 Cr ₹220.89 Cr ₹226.58 Cr
Inventories ₹79.82 Cr ₹67.4 Cr ₹81.21 Cr ₹86.23 Cr
Trade Receivables ₹61.34 Cr ₹68.79 Cr ₹51.35 Cr ₹46.06 Cr
Cash & Equivalents ₹1.21 Cr ₹50.29 Lakh ₹56.95 Lakh ₹1.28 Cr
Equity (Net Worth) ₹229.56 Cr ₹212.05 Cr ₹193.64 Cr ₹188.22 Cr
Equity Share Capital ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr
Borrowings (Non-current) ₹49.96 Cr ₹18.27 Cr ₹33.15 Cr ₹54.94 Cr
Borrowings (Current) ₹58.89 Cr ₹65.75 Cr ₹64.57 Cr ₹43.7 Cr
Total Debt (computed) ₹108.85 Cr ₹84.01 Cr ₹97.71 Cr ₹98.64 Cr
Current Liabilities ₹156.28 Cr ₹142.07 Cr ₹144.56 Cr ₹133.56 Cr
Total Liabilities ₹224.85 Cr ₹177.94 Cr ₹196.88 Cr ₹206.67 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹37.22 Cr ₹34.06 Cr ₹24.31 Cr ₹14.7 Cr -₹11.24 Cr
Investing Cash Flow -₹57.9 Cr -₹15 Cr -₹18.45 Cr -₹31.29 Cr -₹7.14 Cr
Financing Cash Flow ₹21.38 Cr -₹19.12 Cr -₹6.56 Cr ₹16.89 Cr ₹10.83 Cr
Capital Expenditure ₹57.86 Cr ₹15.35 Cr ₹20.87 Cr ₹48.55 Cr ₹51.15 Cr
Free Cash Flow (computed) -₹20.64 Cr ₹18.71 Cr ₹3.44 Cr -₹33.86 Cr -₹62.39 Cr
Dividends Paid ₹45.35 Lakh ₹45.35 Lakh ₹45.34 Lakh ₹45.35 Lakh ₹45.35 Lakh
Net Change in Cash ₹70.55 Lakh -₹6.65 Lakh -₹70.82 Lakh ₹29.19 Lakh -₹7.55 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹75.14 Cr ₹94.78 Cr ₹81.37 Cr ₹82.5 Cr ₹89.11 Cr ₹84.6 Cr ₹78.46 Cr ₹92.55 Cr ₹89.99 Cr ₹72.05 Cr ₹69.26 Cr ₹74.65 Cr
Other Income ₹2.01 Cr ₹18.34 Lakh ₹42.41 Lakh ₹99.59 Lakh ₹2.34 Cr ₹5.74 Lakh ₹2.04 Cr ₹43.92 Lakh ₹2.36 Cr ₹58.18 Lakh ₹33.59 Lakh ₹61.38 Lakh
Total Income ₹77.15 Cr ₹94.97 Cr ₹81.79 Cr ₹83.5 Cr ₹91.45 Cr ₹84.66 Cr ₹80.5 Cr ₹92.99 Cr ₹92.35 Cr ₹72.64 Cr ₹69.6 Cr ₹75.27 Cr
Cost of Materials Consumed ₹35.86 Cr ₹44.74 Cr ₹39.83 Cr ₹28.41 Cr ₹32.74 Cr ₹39.43 Cr ₹35.01 Cr ₹42.72 Cr ₹33.47 Cr ₹39.19 Cr ₹35.75 Cr ₹41.78 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹4.98 Cr -₹1.12 Cr -₹8.81 Cr ₹6.73 Cr ₹6.63 Cr -₹3.84 Cr ₹76.07 Lakh ₹59.56 Lakh ₹10.32 Cr -₹7.9 Cr -₹3.49 Cr ₹2.05 Cr
Employee Benefit Expense ₹16.17 Cr ₹16.7 Cr ₹16.23 Cr ₹16.29 Cr ₹16.47 Cr ₹14.6 Cr ₹14.09 Cr ₹14.38 Cr ₹12.74 Cr ₹12.56 Cr ₹12.28 Cr ₹11.69 Cr
Finance Costs ₹1.42 Cr ₹1.54 Cr ₹1.62 Cr ₹1.87 Cr ₹2.03 Cr ₹2.14 Cr ₹2.14 Cr ₹2.4 Cr ₹2.84 Cr ₹2.34 Cr ₹2.81 Cr ₹2.18 Cr
Depreciation & Amortisation ₹3.85 Cr ₹3.91 Cr ₹3.89 Cr ₹3.82 Cr ₹3.8 Cr ₹3.76 Cr ₹3.76 Cr ₹3.68 Cr ₹3.78 Cr ₹3.73 Cr ₹3.73 Cr ₹3.7 Cr
Other Expenses ₹23.93 Cr ₹20.42 Cr ₹20.55 Cr ₹19.36 Cr ₹25.85 Cr ₹21.65 Cr ₹20.04 Cr ₹18.57 Cr ₹22.1 Cr ₹18.91 Cr ₹16.86 Cr ₹16.61 Cr
Total Expenses ₹76.25 Cr ₹86.19 Cr ₹73.3 Cr ₹76.48 Cr ₹87.52 Cr ₹77.74 Cr ₹75.8 Cr ₹82.35 Cr ₹85.25 Cr ₹68.82 Cr ₹67.94 Cr ₹77.99 Cr
Profit Before Exceptional Items & Tax ₹90.55 Lakh ₹8.78 Cr ₹8.49 Cr ₹7.02 Cr ₹3.93 Cr ₹6.92 Cr ₹4.7 Cr ₹10.64 Cr ₹7.1 Cr ₹3.81 Cr ₹1.66 Cr -₹2.73 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹90.55 Lakh ₹8.78 Cr ₹8.49 Cr ₹7.02 Cr ₹3.93 Cr ₹6.92 Cr ₹4.7 Cr ₹10.64 Cr ₹7.1 Cr ₹3.81 Cr ₹1.66 Cr -₹2.73 Cr
Total Tax Expense ₹56.15 Lakh ₹2.13 Cr ₹2.07 Cr ₹2.64 Cr ₹44.58 Lakh ₹2.06 Cr ₹1.4 Cr ₹3.54 Cr ₹62.71 Lakh -₹31.28 Lakh ₹2.1 Cr ₹1.1 Cr
Net Profit ₹34.4 Lakh ₹6.65 Cr ₹6.43 Cr ₹4.38 Cr ₹3.48 Cr ₹4.85 Cr ₹3.3 Cr ₹7.1 Cr ₹6.47 Cr ₹4.12 Cr -₹44.25 Lakh -₹3.83 Cr
  attributable to Owners ₹43.57 Lakh ₹6.62 Cr ₹6.1 Cr ₹4.16 Cr ₹2.97 Cr ₹5.47 Cr ₹4.67 Cr ₹7 Cr ₹5.9 Cr ₹4.3 Cr ₹66.63 Lakh -₹1.8 Cr
  attributable to NCI -₹9.17 Lakh ₹3.21 Lakh ₹32.27 Lakh ₹22.52 Lakh ₹50.99 Lakh -₹61.24 Lakh -₹1.37 Cr ₹9.82 Lakh ₹57.07 Lakh -₹18.07 Lakh -₹1.11 Cr -₹2.03 Cr
Other Comprehensive Income ₹4.5 Lakh ₹4.27 Lakh ₹3.92 Lakh ₹3.6 Lakh ₹54.03 Lakh -₹14.81 Lakh -₹13.64 Lakh -₹12.5 Lakh -₹47.45 Lakh ₹73,000 ₹67,000 ₹61,000
Total Comprehensive Income ₹38.9 Lakh ₹6.69 Cr ₹6.46 Cr ₹4.42 Cr ₹4.02 Cr ₹4.71 Cr ₹3.16 Cr ₹6.97 Cr ₹6 Cr ₹4.13 Cr -₹43.58 Lakh -₹3.82 Cr
EBITDA (computed) ₹6.17 Cr ₹14.23 Cr ₹13.99 Cr ₹12.71 Cr ₹9.76 Cr ₹12.81 Cr ₹10.6 Cr ₹16.72 Cr ₹13.72 Cr ₹9.87 Cr ₹8.2 Cr ₹3.14 Cr
Basic EPS ₹1.44 ₹21.89 ₹20.19 ₹13.75 ₹9.83 ₹18.08 ₹15.46 ₹23.15 ₹19.53 ₹14.24 ₹2.20 ₹-5.94
Diluted EPS ₹1.44 ₹21.89 ₹20.19 ₹13.75 ₹9.83 ₹18.08 ₹15.46 ₹23.15 ₹19.53 ₹14.24 ₹2.20 ₹-5.94
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹300.99 Cr ₹333.37 Cr ₹300 Cr ₹315.24 Cr ₹345.63 Cr ₹260.26 Cr ₹256.92 Cr
Other Income ₹1.42 Cr ₹3.95 Cr ₹3.84 Cr ₹2.88 Cr ₹1.54 Cr ₹1.33 Cr ₹1.88 Cr
Total Income ₹302.41 Cr ₹337.32 Cr ₹303.84 Cr ₹318.12 Cr ₹347.16 Cr ₹261.59 Cr ₹258.81 Cr
Cost of Materials Consumed ₹145.57 Cr ₹164.43 Cr ₹161.19 Cr ₹189.95 Cr ₹216.16 Cr ₹137.76 Cr ₹155.75 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹6.51 Cr ₹4.69 Cr ₹97.57 Lakh ₹30.1 Lakh -₹7.79 Cr ₹1.9 Cr ₹6.29 Cr
Employee Benefit Expense ₹49.39 Cr ₹45.78 Cr ₹37.94 Cr ₹34.72 Cr ₹32.51 Cr ₹27.11 Cr ₹23.27 Cr
Finance Costs ₹6.03 Cr ₹7.88 Cr ₹8.9 Cr ₹5.09 Cr ₹4.63 Cr ₹4.5 Cr ₹5.09 Cr
Depreciation & Amortisation ₹10.66 Cr ₹10.26 Cr ₹10.25 Cr ₹8.17 Cr ₹7.99 Cr ₹7.21 Cr ₹7.24 Cr
Other Expenses ₹72.06 Cr ₹74.24 Cr ₹65.47 Cr ₹63.86 Cr ₹73.37 Cr ₹63.75 Cr ₹47.82 Cr
Total Expenses ₹277.22 Cr ₹307.28 Cr ₹284.73 Cr ₹302.1 Cr ₹326.88 Cr ₹242.23 Cr ₹245.47 Cr
Profit Before Exceptional Items & Tax ₹25.19 Cr ₹30.04 Cr ₹19.11 Cr ₹16.02 Cr ₹20.28 Cr ₹19.35 Cr ₹13.34 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹2.35 Cr ₹12.69 Cr ₹0 ₹0
Profit Before Tax ₹25.19 Cr ₹30.04 Cr ₹19.11 Cr ₹18.37 Cr ₹32.98 Cr ₹19.35 Cr ₹13.34 Cr
Total Tax Expense ₹7.41 Cr ₹8.67 Cr ₹6.05 Cr ₹5.15 Cr ₹7.6 Cr ₹6.19 Cr ₹4.19 Cr
Net Profit ₹17.78 Cr ₹21.37 Cr ₹13.07 Cr ₹13.22 Cr ₹25.38 Cr ₹13.17 Cr ₹9.15 Cr
Other Comprehensive Income ₹7.81 Lakh ₹3.01 Lakh -₹41.19 Lakh ₹4.99 Lakh -₹5.04 Lakh -₹8.75 Lakh -₹32.35 Lakh
Total Comprehensive Income ₹17.85 Cr ₹21.4 Cr ₹12.65 Cr ₹13.27 Cr ₹25.33 Cr ₹13.08 Cr ₹8.82 Cr
EBITDA (computed) ₹41.89 Cr ₹48.18 Cr ₹38.27 Cr ₹29.29 Cr ₹32.9 Cr ₹31.07 Cr ₹25.67 Cr
Basic EPS ₹58.80 ₹70.69 ₹43.22 ₹43.72 ₹83.95 ₹43.56 ₹30.26
Diluted EPS ₹58.80 ₹70.69 ₹43.22 ₹43.72 ₹83.95 ₹43.56 ₹30.26
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹403.34 Cr ₹358.31 Cr ₹347.38 Cr ₹337.39 Cr
Non-current Assets ₹221.63 Cr ₹180.52 Cr ₹172.88 Cr ₹169.8 Cr
Current Assets ₹181.71 Cr ₹177.79 Cr ₹174.49 Cr ₹167.59 Cr
Property, Plant & Equipment ₹188.61 Cr ₹148.41 Cr ₹135.78 Cr ₹137.83 Cr
Inventories ₹69.81 Cr ₹60.58 Cr ₹74.59 Cr ₹80.46 Cr
Trade Receivables ₹54.26 Cr ₹64.53 Cr ₹49.35 Cr ₹45.52 Cr
Cash & Equivalents ₹39.89 Lakh ₹40.13 Lakh ₹33.49 Lakh ₹15.14 Lakh
Equity (Net Worth) ₹214.58 Cr ₹197.18 Cr ₹176.23 Cr ₹164.03 Cr
Equity Share Capital ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr ₹3.02 Cr
Borrowings (Non-current) ₹35.18 Cr ₹17.31 Cr ₹28.31 Cr ₹45.97 Cr
Borrowings (Current) ₹57.93 Cr ₹61.86 Cr ₹60.41 Cr ₹39.17 Cr
Total Debt (computed) ₹93.11 Cr ₹79.17 Cr ₹88.73 Cr ₹85.14 Cr
Current Liabilities ₹133.02 Cr ₹124.3 Cr ₹122.7 Cr ₹110.57 Cr
Total Liabilities ₹188.76 Cr ₹161.14 Cr ₹171.15 Cr ₹173.36 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹38.43 Cr ₹28.03 Cr ₹14.75 Cr ₹1.88 Cr -₹14.66 Cr
Investing Cash Flow -₹49.28 Cr -₹13.77 Cr -₹13.75 Cr -₹27.96 Cr -₹7.49 Cr
Financing Cash Flow ₹10.85 Cr -₹14.2 Cr -₹81.83 Lakh ₹25.29 Cr ₹14.63 Cr
Capital Expenditure ₹49.24 Cr ₹14.09 Cr ₹13.72 Cr ₹33.91 Cr ₹24.96 Cr
Free Cash Flow (computed) -₹10.81 Cr ₹13.95 Cr ₹1.03 Cr -₹32.03 Cr -₹39.62 Cr
Dividends Paid ₹45.35 Lakh ₹45.35 Lakh ₹45.34 Lakh ₹45.35 Lakh ₹45.35 Lakh
Net Change in Cash -₹24,000 ₹6.64 Lakh ₹18.36 Lakh -₹79.5 Lakh -₹7.52 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹63.38 Cr ₹80.72 Cr ₹77.84 Cr ₹79.04 Cr ₹85.43 Cr ₹82.88 Cr ₹78.5 Cr ₹86.57 Cr ₹86.37 Cr ₹71.23 Cr ₹67.84 Cr ₹74.56 Cr
Other Income ₹96.92 Lakh ₹7.84 Lakh ₹43.64 Lakh ₹1.01 Cr ₹2.2 Cr ₹6.13 Lakh ₹1.26 Cr ₹42.98 Lakh ₹2.28 Cr ₹64.04 Lakh ₹33.47 Lakh ₹58.3 Lakh
Total Income ₹64.35 Cr ₹80.8 Cr ₹78.28 Cr ₹80.05 Cr ₹87.63 Cr ₹82.94 Cr ₹79.75 Cr ₹87 Cr ₹88.65 Cr ₹71.87 Cr ₹68.18 Cr ₹75.14 Cr
Cost of Materials Consumed ₹33.02 Cr ₹39.36 Cr ₹41.6 Cr ₹33.64 Cr ₹38.95 Cr ₹43.14 Cr ₹37.6 Cr ₹44.75 Cr ₹37.51 Cr ₹42.71 Cr ₹37.25 Cr ₹43.73 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹7.34 Cr -₹21.45 Lakh -₹4.36 Cr ₹5.4 Cr ₹5.86 Cr -₹3.31 Cr ₹1.26 Cr ₹88.04 Lakh ₹10.21 Cr -₹6.97 Cr -₹3.62 Cr ₹1.35 Cr
Employee Benefit Expense ₹12.06 Cr ₹12.46 Cr ₹12.38 Cr ₹12.5 Cr ₹12.46 Cr ₹11.24 Cr ₹10.9 Cr ₹11.18 Cr ₹9.55 Cr ₹9.7 Cr ₹9.57 Cr ₹9.13 Cr
Finance Costs ₹1.34 Cr ₹1.46 Cr ₹1.51 Cr ₹1.73 Cr ₹1.84 Cr ₹1.96 Cr ₹1.92 Cr ₹2.16 Cr ₹2.56 Cr ₹2.04 Cr ₹2.48 Cr ₹1.82 Cr
Depreciation & Amortisation ₹2.66 Cr ₹2.69 Cr ₹2.68 Cr ₹2.63 Cr ₹2.62 Cr ₹2.56 Cr ₹2.57 Cr ₹2.5 Cr ₹2.62 Cr ₹2.55 Cr ₹2.55 Cr ₹2.53 Cr
Other Expenses ₹19.44 Cr ₹17.56 Cr ₹17.43 Cr ₹16.67 Cr ₹22.57 Cr ₹18.73 Cr ₹16.94 Cr ₹16 Cr ₹18.3 Cr ₹16.77 Cr ₹15.17 Cr ₹15.23 Cr
Total Expenses ₹61.18 Cr ₹73.31 Cr ₹71.23 Cr ₹72.57 Cr ₹84.29 Cr ₹74.33 Cr ₹71.19 Cr ₹77.46 Cr ₹80.74 Cr ₹66.8 Cr ₹63.4 Cr ₹73.78 Cr
Profit Before Exceptional Items & Tax ₹3.18 Cr ₹7.49 Cr ₹7.05 Cr ₹7.48 Cr ₹3.33 Cr ₹8.61 Cr ₹8.56 Cr ₹9.54 Cr ₹7.91 Cr ₹5.07 Cr ₹4.77 Cr ₹1.36 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹3.18 Cr ₹7.49 Cr ₹7.05 Cr ₹7.48 Cr ₹3.33 Cr ₹8.61 Cr ₹8.56 Cr ₹9.54 Cr ₹7.91 Cr ₹5.07 Cr ₹4.77 Cr ₹1.36 Cr
Total Tax Expense ₹94.3 Lakh ₹2.08 Cr ₹2.07 Cr ₹2.32 Cr ₹65.9 Lakh ₹2.38 Cr ₹2.55 Cr ₹3.08 Cr ₹1.97 Cr ₹1.76 Cr ₹1.66 Cr ₹65.76 Lakh
Net Profit ₹2.23 Cr ₹5.41 Cr ₹4.98 Cr ₹5.16 Cr ₹2.68 Cr ₹6.23 Cr ₹6.01 Cr ₹6.46 Cr ₹5.93 Cr ₹3.31 Cr ₹3.12 Cr ₹70.05 Lakh
Other Comprehensive Income ₹5.21 Lakh ₹91,000 ₹87,000 ₹83,000 ₹40.08 Lakh -₹13.39 Lakh -₹12.36 Lakh -₹11.33 Lakh -₹45.32 Lakh ₹1.51 Lakh ₹1.37 Lakh ₹1.25 Lakh
Total Comprehensive Income ₹2.29 Cr ₹5.42 Cr ₹4.99 Cr ₹5.17 Cr ₹3.08 Cr ₹6.09 Cr ₹5.88 Cr ₹6.35 Cr ₹5.48 Cr ₹3.33 Cr ₹3.13 Cr ₹71.3 Lakh
EBITDA (computed) ₹7.17 Cr ₹11.64 Cr ₹11.24 Cr ₹11.85 Cr ₹7.8 Cr ₹13.13 Cr ₹13.06 Cr ₹14.2 Cr ₹13.09 Cr ₹9.66 Cr ₹9.81 Cr ₹5.71 Cr
Basic EPS ₹7.39 ₹17.88 ₹16.46 ₹17.06 ₹8.85 ₹20.60 ₹19.87 ₹21.37 ₹19.63 ₹10.96 ₹10.31 ₹2.32
Diluted EPS ₹7.39 ₹17.88 ₹16.46 ₹17.06 ₹8.85 ₹20.60 ₹19.87 ₹21.37 ₹19.63 ₹10.96 ₹10.31 ₹2.32
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Haleos Labs Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Haleos Labs Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 72.11%, domestic institutional investors hold 0.30%, retail and other public shareholders hold 27.60% of Haleos Labs Limited. The company had 6,937 shareholders on record.

Promoters: 72.11%DII (Domestic Institutional): 0.30%Retail & Others: 27.60%
Mar 2026
QUARTER
72.11% Promoters
0.30% DII (Domestic Institutional)
27.60% Retail & Others
Promoter holding - history
Now 72.11% · Mar 2026High 72.11% · Mar 2026Low 67.69% · Dec 2021
66%68%70%72%74%Aug 2017Jun 2019Jun 2021Jun 2023Jun 2025Aug 2017: 67.99%Sep 2017: 67.99%Dec 2017: 67.99%Mar 2018: 67.99%Jun 2018: 67.99%Sep 2018: 67.99%Dec 2018: 67.99%Mar 2019: 67.99%Jun 2019: 67.99%Sep 2019: 67.99%Dec 2019: 67.99%Mar 2020: 68.00%Jun 2020: 68.00%Sep 2020: 68.24%Dec 2020: 68.26%Mar 2021: 68.26%Jun 2021: 67.74%Sep 2021: 67.74%Dec 2021: 67.69%Mar 2022: 68.96%Jun 2022: 69.85%Sep 2022: 69.86%Dec 2022: 70.32%Mar 2023: 70.32%Jun 2023: 70.32%Sep 2023: 70.32%Dec 2023: 70.68%Mar 2024: 71.19%Jun 2024: 71.41%Sep 2024: 71.41%Dec 2024: 71.41%Mar 2025: 71.41%Jun 2025: 71.41%Sep 2025: 71.41%Dec 2025: 71.80%Mar 2026: 72.11%67.69%72.11%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters72.11%71.80%71.41%71.41%71.41%71.41%
Public27.89%28.20%28.59%28.59%28.59%28.59%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Promoters72.11%71.41%71.19%70.32%68.96%68.26%68.00%67.99%67.99%
Public27.89%28.59%28.81%29.68%31.04%31.74%32.00%32.01%32.01%
Promoter change (YoY, %pts)+0.70+0.22+0.87+1.36+0.70+0.26+0.01+0.00-

Board & Governance of Haleos Labs Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Haleos Labs Limited has 7 directors - 4 independent and 3 executive. The board is chaired by VEERA VENKATA SATYANARAYANA MURTHY TALLURI.

DirectorPositionOn board sinceListed boards
VEERA VENKATA SATYANARAYANA MURTHY TALLURI Executive Director · MD · Chairperson 2016-04-01 1
SARATH KUMAR PAKALAPATI Non-Executive - Independent Director 2017-05-25 1
VENKATA PRAVEEN TALLURI Executive Director 2020-08-21 1
SUDEEPTHI GOPINEEDI Executive Director 2021-09-02 1
MANNAM MALAKONDAIAH Non-Executive - Independent Director 2021-11-13 2
SRINIVAS SAMAVEDAM Non-Executive - Independent Director 2021-11-13 1
SUNDARAMMA PATIBANDLA Non-Executive - Independent Director 2025-02-12 1
Board Committees
CommitteeMembers
Audit Committee SARATH KUMAR PAKALAPATI (Chairperson), MANNAM MALAKONDAIAH, VEERA VENKATA SATYANARAYANA MURTHY TALLURI, SUNDARAMMA PATIBANDLA
Nomination and remuneration committee MANNAM MALAKONDAIAH (Chairperson), SARATH KUMAR PAKALAPATI, SRINIVAS SAMAVEDAM, SUNDARAMMA PATIBANDLA
Stakeholders Relationship Committee SARATH KUMAR PAKALAPATI (Chairperson), VEERA VENKATA SATYANARAYANA MURTHY TALLURI, SUNDARAMMA PATIBANDLA
Corporate Social Responsibility Committee VEERA VENKATA SATYANARAYANA MURTHY TALLURI (Chairperson), VENKATA PRAVEEN TALLURI, MANNAM MALAKONDAIAH, SRINIVAS SAMAVEDAM

Group Structure of Haleos Labs Limited

Haleos Labs Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Haleos Labs Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Mahi Drugs Private Limited U24233AP2012PTC084875 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Haleos Labs Limited

Open charges
₹133.44 Cr
Satisfied charges
₹67.83 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹100.00 Cr
Others₹33.44 Cr
Latest charge details
DateLenderAmountStatus
12 Aug 2022 Hdfc Bank Limited ₹30 Cr Open
31 Mar 2022 Hdfc Bank Limited ₹70 Cr Open
29 Mar 2022 Others ₹3.44 Cr Open
26 May 2017 Others ₹30 Cr Open
16 Mar 2021 Others ₹7.83 Cr Satisfied

Total charge records: 8 View all charges

Employees and EPFO Compliance at Haleos Labs Limited

Haleos Labs Limited has a workforce of 558 employees as of Mar 22, 2024.

Employee count
558
Active EPFO establishments
3
Employee growth
-0.71%
Premium access

Employee and EPFO history for Haleos Labs Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Haleos Labs Limited

Premium access

GST registrations and filing compliance for Haleos Labs Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Haleos Labs Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Haleos Labs Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Haleos Labs Limited

Premium access

MSME payment history for Haleos Labs Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Haleos Labs Limited

Premium access

Corporate group structure for Haleos Labs Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Haleos Labs Limited

Premium access

MCA filings and documents for Haleos Labs Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Haleos Labs Limited

Charges
16 Jun 2026
A charge registered on 25 Sep 2018 via Charge ID 100206545 with Others was fully satisfied on 16 Jun 2026.
Charges
23 Jan 2026
A charge with Hdfc Bank Limited of Rs. 70.00 Cr registered on 31 Mar 2022 with Charge ID 100571180 was modified on 23 Jan 2026.
Activity
30 Sep 2025
Haleos Labs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
20 Aug 2025
A charge registered on 16 Mar 2021 via Charge ID 100425999 with Others was fully satisfied on 20 Aug 2025.
Activity
31 Mar 2025
Haleos Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
05 Mar 2024
A charge with Others of Rs. 30.00 Cr registered on 26 May 2017 with Charge ID 100100545 was modified on 05 Mar 2024.

Recent News on Haleos Labs Limited

Frequently Asked Questions about Haleos Labs Limited

Haleos Labs Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 31 May 2006 (20+ years old) and is registered under CIN L74930TG2006PLC050223. Listed on BSE: 540679 and NSE: SMSLIFE. The company has 558 employees.

Haleos Labs Limited reported revenue of ₹333.79 Cr for FY 2026 (down 3.17% YoY) based on consolidated NSE filings.

The current directors of Haleos Labs Limited are:

The primary industry of Haleos Labs Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Haleos Labs Limited is listed on both BSE (code: 540679) and NSE (symbol: SMSLIFE).

Haleos Labs Limited can be reached at the registered office: Plot No.19 – Iii Road No.71 Jubilee Hills Opp. Bharatiya Vidya Bhavan Public School, Hyderabad, Telangana, India – 500096, or through the website smslife.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available